^V599EB-RAF is an oncogene in melanocytesWELLBROCK, Claudia; OGILVIE, Lesley; HEDLEY, Douglas et al.Cancer research (Baltimore). 2004, Vol 64, Num 7, pp 2338-2342, issn 0008-5472, 5 p.Article

Targets of Raf in tumorigenesisNIAULT, Théodora S; BACCARINI, Manuela.Carcinogenesis (New York. Print). 2010, Vol 31, Num 7, pp 1165-1174, issn 0143-3334, 10 p.Article

Viral Oncolysis That Targets Raf-1 Signaling Control of Nuclear TransportRIOLOBOS, Laura; VALLE, Noelia; HERNANDO, Eva et al.Journal of virology. 2010, Vol 84, Num 4, pp 2090-2099, issn 0022-538X, 10 p.Article

C-Raf Is Associated with Disease Progression and Cell Proliferation in a Subset of MelanomasJILAVEANU, Lucia B; ZITO, Christopher R; AZIZ, Saadia A et al.Clinical cancer research (Print). 2009, Vol 15, Num 18, pp 5704-5713, issn 1078-0432, 10 p.Article

Activation of Raf-1 and mitogen-activated protein kinases during monocytic differentiation of human myeloid leukemia cellsSURENDER KHARBANDA; AHAMED SALEEM; EMOTO, Y et al.The Journal of biological chemistry (Print). 1994, Vol 269, Num 2, pp 872-878, issn 0021-9258Article

C-RAF Mutations Confer Resistance to RAF InhibitorsANTONY, Rajee; EMERY, Caroline M; SAWYER, Allison M et al.Cancer research (Chicago, Ill.). 2013, Vol 73, Num 15, pp 4840-4851, issn 0008-5472, 12 p.Article

Raf and the road to cell survival: a tale of bad spells, ring bearers and detoursTROPPMAIR, Jakob; RAPP, Ulf R.Biochemical pharmacology. 2003, Vol 66, Num 8, pp 1341-1345, issn 0006-2952, 5 p.Conference Paper

Molecular organization of the human Raf-1 promoter regionBECK, T. W; BRENNSCHEIDT, U; SITHANANDAM, G et al.Molecular and cellular biology (Print). 1990, Vol 10, Num 7, pp 3325-3333, issn 0270-7306, 9 p.Article

Combinatorial Treatments That Overcome PDGFRβ-Driven Resistance of Melanoma Cells to ^V600EB-RAF InhibitionHUBING SHI; XIANGJU KONG; RIBAS, Antoni et al.Cancer research (Chicago, Ill.). 2011, Vol 71, Num 15, pp 5067-5074, issn 0008-5472, 8 p.Article

Regulation of Pyruvate Kinase Type M2 by A-Raf : A Possible Glycolytic Stop or Go MechanismMAZUREK, Sybille; DREXLER, Hannes C. A; TROPPMAIR, Jakob et al.Anticancer research. 2007, Vol 27, Num 6B, pp 3963-3971, issn 0250-7005, 9 p.Article

Mutant ^V599EB-raf regulates growth and vascular development of malignant melanoma tumorsSHARMA, Arati; TRIVEDI, Nishit R; ZIMMERMAN, Melissa A et al.Cancer research (Baltimore). 2005, Vol 65, Num 6, pp 2412-2421, issn 0008-5472, 10 p.Article

An inhibitory Raf-1 mutant suppresses expression of a subset of v-raf-activated genesMILTENBERGER, R. J; CORTNER, J; FARNHAM, P. J et al.The Journal of biological chemistry (Print). 1993, Vol 268, Num 21, pp 15674-15680, issn 0021-9258Article

Molecular cloning and characterization of an activated human c-raf-1 geneFUKUI, M; YAMAMOTO, T; KAWAI, S et al.Molecular and cellular biology (Print). 1987, Vol 7, Num 5, pp 1776-1781, issn 0270-7306Article

Targeting ^V600EB-Raf and Akt3 Using Nanoliposomal-Small Interfering RNA Inhibits Cutaneous Melanocytic Lesion DevelopmentTRAN, Melissa A; GOWDA, Raghavendra; SHARMA, Arati et al.Cancer research (Chicago, Ill.). 2008, Vol 68, Num 18, pp 7638-7649, issn 0008-5472, 12 p.Article

KSR and CNK: two scaffolds regulating RAS-mediated RAF activationCLAPERON, A; THERRIEN, M.Oncogene (Basingstoke). 2007, Vol 26, Num 22, pp 3143-3158, issn 0950-9232, 16 p.Article

Mutations of C-RAF are rare in human cancer because C-RAF has a low basal kinase activity compared with B-RAFEMUSS, Victoria; GARNETT, Mathew; MASON, Clive et al.Cancer research (Baltimore). 2005, Vol 65, Num 21, pp 9719-9726, issn 0008-5472, 8 p.Article

Conferring specificity on the ubiquitous Raf/MEK signalling pathwayO'NEILL, E; KOLCH, W.British journal of cancer. 2004, Vol 90, Num 2, pp 283-288, issn 0007-0920, 6 p.Article

Mitogen-activated protein kinase/extracellular signal-regulated protein kinase activation by oncogenes, serum, and 12-0-tetradecanoylphorbol-13-acetate requires raf and is necessary for transformationTROPPMAIR, J; BRUDER, J. T; MUNOZ, H et al.The Journal of biological chemistry (Print). 1994, Vol 269, Num 9, pp 7030-7035, issn 0021-9258Article

Identification of the major phosphorylation sites of the Raf-1 kinaseMORRISON, D. K; HEIDECKER, G; RAPP, U. R et al.The Journal of biological chemistry (Print). 1993, Vol 268, Num 23, pp 17309-17316, issn 0021-9258Article

Discovery and optimization of thieno[2,3-d]pyrimidines as B-Raf inhibitorsPACKARD, Garrick K; PAPA, Patrick; MCCARRICK, Margaret A et al.Bioorganic & medicinal chemistry letters (Print). 2012, Vol 22, Num 1, pp 747-752, issn 0960-894X, 6 p.Article

Histogenesis and clonality of pancreatic tumors induced by ν-myc and ν-raf oncogenes in NFS/N miceFREDRICKSON, T. N; HARTLEY, J. W; WOLFORD, N. K et al.The American journal of pathology. 1988, Vol 131, Num 3, pp 444-451, issn 0002-9440Article

Raf kinase inhibitor protein : mechanism of loss of expression and association with genomic instabilityAL-MULLA, F; HAGAN, S; AL-ALI, W et al.Journal of clinical pathology. 2008, Vol 61, Num 4, pp 524-529, issn 0021-9746, 6 p.Article

Two transforming C-RAF germ-line mutations identified in patients with therapy-related acute myeloid leukemiaZEBISCH, Armin; STABER, Philipp B; WINDPASSINGER, Christian et al.Cancer research (Baltimore). 2006, Vol 66, Num 7, pp 3401-3408, issn 0008-5472, 8 p.Article

CD4⁺ T-cell recognition of mutated B-RAF in melanoma patients harboring the V599E mutationSHARKEY, Melinda S; LIZEE, Gregory; GONZALES, Monica I et al.Cancer research (Baltimore). 2004, Vol 64, Num 5, pp 1595-1599, issn 0008-5472, 5 p.Article

B-raf oncogene : activation of rearrangements and assignment to humans chromosome 7KAMIYAMA, T; AOKI, N; YUASA, Y et al.Japanese journal of cancer research. 1993, Vol 84, Num 3, pp 250-256, issn 0910-5050Article